Maya Ilouze

Petah Tiqwa, M, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival.

Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival.

Journal: Journal of global oncology
Published: May 09, 2019

Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi).

Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi).

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 19, 2018

The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer.

The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 18, 2018

THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER

THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER

Journal: Harefuah
Published: December 04, 2017

Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.

Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.

Journal: Clinical breast cancer
Published: September 05, 2017

Cancer metabolism: the volatile signature of glycolysis-in vitro model in lung cancer cells.

Cancer metabolism: the volatile signature of glycolysis-in vitro model in lung cancer cells.

Journal: Journal of breath research
Published: January 10, 2017

Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.

Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 19, 2016

Detection of Lung Cancer and EGFR Mutation by Electronic Nose System.

Detection of Lung Cancer and EGFR Mutation by Electronic Nose System.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 19, 2016

RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.

RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.

Journal: Clinical lung cancer
Published: June 13, 2016

Cancerous glucose metabolism in lung cancer-evidence from exhaled breath analysis.

Cancerous glucose metabolism in lung cancer-evidence from exhaled breath analysis.

Journal: Journal of breath research
Published: June 09, 2016

Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.

Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 05, 2016

Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.

Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 14, 2015
Showing 1-12 of 22

Last Updated: 09/26/2026